2-Bromo-5-Methylthiazole

In palladium-catalyzed Suzuki-Miyaura cross-coupling sequences, the C2 bromine atom of 2-bromo-5-methylthiazole functions as the electrophilic partner, reacting with aryl, heteroaryl, and vinyl boronic acids to construct biaryl architectures central to drug candidate libraries. The electron-withdrawing character of the thiazole ring nitrogen activates the C–Br bond toward oxidative addition, permitting catalyst loadings as low as 0.5 mol% Pd when triarylphosphine ligands are employed. Typical coupling protocols utilize Pd(PPh₃)₄ at 1–3 mol% loading in a degassed 4:1 THF/H₂O or 3:1 dioxane/H₂O solvent system with 2.0–3.0 equivalents of aqueous K₂CO₃ or K₃PO₄ as base. The reaction mixture is maintained under inert atmosphere at 75–90°C for 8–24 hours, with conversion monitored by GC-MS or HPLC at 254 nm. Microwave-assisted protocols reduce reaction times to 30–90 minutes at 110–130°C in sealed vials, though pressure buildup in batch-mode microwave reactors exceeding 20 bar requires careful vessel selection. A persistent side reaction is protodebromination, wherein the C2 bromine is reductively displaced by hydrogen derived from the solvent or base system. This pathway becomes significant above 95°C in aqueous dioxane and can consume 5–15% of the starting material if rigorous oxygen exclusion is not maintained. The 5-methyl substituent exerts a modest electron-donating effect that decelerates oxidative addition relative to 2-bromothiazole, necessitating a 5–10°C upward adjustment in reaction temperature when bulky boronic acids are employed. On production-scale equipment—typically 100–500 L glass-lined reactors with anchor agitators operating at 80–120 rpm—mass transfer limitations at the organic-aqueous interface can extend reaction times beyond laboratory predictions. Batch records from multi-kilogram campaigns indicate that nitrogen sparging through a dip tube at 0.5–1.0 L/min per 100 L reactor volume improves reproducibility by stripping dissolved oxygen before catalyst addition.

Catalyst System	Loading (mol%)	Base/Solvent	Temperature Window	Documented Limitation
Pd(PPh₃)₄	1–5	K₂CO₃ / THF-H₂O	70–85°C	Phosphine oxidation above 90°C; catalyst decomposition in absence of excess ligand
PdCl₂(dppf)·CH₂Cl₂	2–3	K₃PO₄ / dioxane-H₂O	80–95°C	Ferrocenyl ligand leaching at pH < 9; residual iron contamination complicates API purity
Pd₂(dba)₃ / SPhos	0.5–1.5	K₃PO₄ / toluene-H₂O	85–100°C	dba-derived impurities co-elute with product on silica; requires activated carbon treatment
Pd(OAc)₂ / XPhos	1–2	Cs₂CO₃ / DME-H₂O	75–90°C	Cesium carbonate cost escalates at scale; residual Cs levels must be validated per ICH Q3D
SPhos Pd G3 (precatalyst)	0.25–1	K₂CO₃ / THF-H₂O	60–80°C	Precatalyst sensitivity to moisture requires glovebox handling; limited commercial availability in bulk

What Structural Features Make 2-Bromo-5-Methylthiazole a Preferred Intermediate for Strobilurin-Analogue Fungicides?

Thiazole-containing fungicidal scaffolds that mimic the strobilurin pharmacophore or incorporate thiazole as a heterocyclic bioisostere of oxazole and pyridine rings demand a C2-functionalizable thiazole building block with a defined substitution pattern at the remaining ring positions. The 5-methyl group in 2-bromo-5-methylthiazole occupies the position that, in the final active ingredient, modulates lipophilicity (calculated ClogP values shift by approximately +0.5 to +0.7 log units relative to the des-methyl analogue) and influences metabolic stability at the cytochrome P450 3A4 isoform. Synthesis of these agrochemical candidates proceeds through a Suzuki coupling at C2 to install a substituted phenyl or pyridyl ring, followed by elaboration of the methyl group—when required—via radical bromination with N-bromosuccinimide and AIBN initiation in refluxing CCl₄ or chlorobenzene at 77–132°C, generating a C5 bromomethyl intermediate for subsequent nucleophilic displacement. This sequence mirrors the industrial route to several development-phase fungicides where the thiazole ring serves as the central scaffold linking a lipophilic aryl tail to a polar pharmacophore head. During radical bromination at C5, dibrominated byproducts form at conversion exceeding 70%, and the reaction is typically quenched at 60–65% monobromination to avoid an intractable purification. The monobrominated intermediate is isolated via vacuum distillation at 0.5–2 mmHg with a vapor temperature of 105–125°C, though thermal sensitivity of the bromomethylthiazole limits pot residence time to under 4 hours at temperature. Process safety evaluations mandate differential scanning calorimetry screening of the bromination reaction mass; exotherm onset has been recorded at 140–160°C for neat NBS/thiazole mixtures, and the semi-batch addition rate of NBS is calibrated to maintain internal temperature below 90°C with jacket cooling capacity of at least 1.5 kW/m² of heat transfer area.The Buchwald-Hartwig amination of 2-bromo-5-methylthiazole with primary and secondary amines broadens the agrochemical applicability beyond Suzuki-derived biaryl systems. Using Pd₂(dba)₃ (0.5–2 mol%), a biarylphosphine ligand such as RuPhos or BrettPhos (1–4 mol% relative to Pd), and NaOtBu or LiHMDS as base in toluene or 2-MeTHF at 65–100°C, the C2 bromine is displaced by aliphatic amines, anilines, and heterocyclic amines to yield C2-aminated thiazoles. This transformation is particularly relevant for generating N-arylthiazol-2-amine motifs found in insecticidal compounds targeting the nicotinic acetylcholine receptor. The reaction tolerates the 5-methyl substituent without competitive deprotonation, and the methyl group's steric influence on the adjacent C4 position is negligible at the distances involved in palladium-ligand coordination. However, amine substrates bearing additional halogen substituents—particularly aryl bromides or iodides—can undergo competitive oxidative addition, leading to oligomeric impurities that precipitate from the reaction mixture as dark, intractable solids. In such cases, the use of the 2-bromo-5-methylthiazole as the limiting reagent in slight excess (1.05–1.1 equivalents) biases the system toward desired mono-amination and reduces oligomer formation to below 3 area% by HPLC.When elaborated via sequential C2-functionalization and C5-methyl retention, the thiazole core provides a geometrically constrained heterocyclic platform for type II kinase inhibitor design, where the ring nitrogen serves as a hydrogen bond acceptor engaging the hinge region of the ATP-binding pocket and the C2 aryl substituent occupies the hydrophobic back pocket. The 5-methyl group projects into a region of the binding site that, in kinases such as c-KIT and PDGFRα/β, tolerates small alkyl substituents without steric clash, and its presence can improve selectivity against kinases with restricted hydrophobic pockets at the corresponding position—most notably the VEGFR2 kinase, where a bulkier substituent would be excluded. Crystallographic data for thiazole-based inhibitors co-crystallized with c-KIT (PDB entries for structurally related 2-aryl-5-methylthiazole ligands) reveal a conserved hydrogen bond distance of 2.8–3.1 Å between the thiazole nitrogen and the backbone NH of Cys673 in the hinge region. Synthesis of the inhibitor scaffold from 2-bromo-5-methylthiazole proceeds through a palladium-catalyzed Suzuki coupling at C2 to install a 4-(4-methylpiperazin-1-ylmethyl)phenyl or related solubilizing aryl group, with the coupling executed at 85°C in 5:1 dioxane/H₂O using Pd(dppf)Cl₂·CH₂Cl₂ at 3 mol% and K₃PO₄ as base. The crude coupling product is typically purified by silica gel chromatography with a hexane/ethyl acetate gradient (95:5 to 60:40), and residual palladium is reduced to below 10 ppm by treatment with a thiol-functionalized silica scavenger or by recrystallization from 2-propanol/water (7:3). Residual palladium is quantified by ICP-MS per USP 〈232〉 / ICH Q3D, with the oral PDE for palladium set at 100 μg/day (parenteral: 10 μg/day). Batch records for 50–200 kg campaigns document that residual Pd after scavenger treatment averages 3–8 ppm, falling comfortably within the oral exposure limit.

Conjugated Polymer Donor-Acceptor Motifs Incorporating Thiazole π-Spacer Units

The electron-deficient nature of the thiazole ring, arising from the imine nitrogen within the five-membered heterocycle, positions 2-bromo-5-methylthiazole as a monomer precursor for π-conjugated polymers employed in bulk heterojunction organic photovoltaic cells and organic field-effect transistors. Copolymerization with electron-rich comonomers—typically 2,5-bis(trimethylstannyl)thiophene or carbazole-based distannyl monomers—via Stille polycondensation proceeds in anhydrous chlorobenzene or 1,2-dichlorobenzene at 110–140°C using Pd₂(dba)₃ (2–4 mol%) and P(o-tolyl)₃ as the catalytic system. The 5-methyl substituent on the thiazole ring imparts solubility to the growing polymer chain, reducing precipitation during polymerization and enabling number-average molecular weights (Mₙ) in the range of 15–35 kDa (vs. polystyrene standards, THF eluent, refractive index detection). Without the methyl substituent, the homopolymer and many copolymers of unsubstituted 2,5-thiazole exhibit limited solubility in common processing solvents, restricting film formation to aggressive solvent systems such as hot 1,2,4-trichlorobenzene or N-methyl-2-pyrrolidone above 120°C. The bromine at C2 serves as one of two required leaving groups for AA/BB-type step-growth polymerization; the complementary C5 position requires independent functionalization—typically via lithiation with LDA at −78°C in anhydrous THF followed by quenching with trimethyltin chloride to install the distannyl functionality, or via halogen dance chemistry to migrate the bromine and enable C5-selective coupling. The molecular weight dispersity (Đ) of polymers synthesized from the 2-bromo-5-methylthiazole monomer typically falls between 1.8 and 2.5 when measured by GPC against polystyrene calibrants, which is characteristic of Stille step-growth polycondensation with incomplete end-group stoichiometric matching. End-capping with 2-(tributylstannyl)thiophene followed by 2-bromothiophene in sequential addition reduces residual bromine termini that act as exciton recombination sites.Processing of the resultant polymer into thin-film devices on ITO-coated glass substrates via blade coating or slot-die coating at 60–80°C from chlorobenzene or o-xylene solutions (10–25 mg/mL) yields active-layer films of 80–150 nm thickness as measured by stylus profilometry. Power conversion efficiencies for devices incorporating thiazole-based donor polymers blended with PC₆₁BM or PC₇₁BM acceptors in a 1:1.2 to 1:2.0 donor:acceptor weight ratio have been documented in the range of 3.5–6.2% under AM 1.5G illumination at 100 mW/cm², though published data for polymers specifically derived from 2-bromo-5-methylthiazole remains limited to a small number of research-group studies. The open-circuit voltage (Vₒc) of thiazole-containing active layers is generally 0.1–0.2 V higher than that of analogous thiophene-based polymers due to the deeper HOMO energy level imparted by the electron-withdrawing thiazole unit, a property confirmed by cyclic voltammetry with ferrocene/ferrocenium internal referencing per IUPAC recommendations.

When 2-Bromo-5-Methylthiazole Serves as the Entry Point to N,S-Heterocyclic Carbene Ligand Precursors

The thiazole ring, upon quaternization at nitrogen with an alkylating agent and subsequent deprotonation at C2, generates a nucleophilic carbene center that coordinates transition metals in a manner analogous to imidazole-derived N-heterocyclic carbenes but with the sulfur atom modulating the electronic properties at the metal center. 2-Bromo-5-methylthiazole is converted to the corresponding thiazolium salt by alkylation of the ring nitrogen with methyl iodide, ethyl bromide, or benzyl bromide in acetonitrile or acetone at 40–60°C over 12–24 hours. The bromide counterion is exchanged for tetrafluoroborate or hexafluorophosphate via metathesis with AgBF₄ or KPF₆ to yield a non-hygroscopic, crystalline thiazolium salt amenable to storage under ambient conditions. The 2-bromo substituent in the resulting thiazolium salt is not directly involved in carbene generation—the C2 position bearing the bromine is the site that must be deprotonated to form the carbene, and the bromine must first be displaced by a hydride source or by direct metalation. This creates a synthetic bottleneck: the bromide at C2, which was the valuable cross-coupling handle in pharmaceutical applications, becomes an obstacle in the carbene-forming sequence. A common workaround involves palladium-catalyzed hydrodebromination of 2-bromo-5-methylthiazole using Pd/C (5–10 wt%, 10% Pd on carbon) under 1–3 bar H₂ in ethanol or ethyl acetate at 25–40°C, yielding 5-methylthiazole in near-quantitative conversion. The debrominated thiazole is then quaternized and deprotonated with KOtBu or NaH in THF at −20 to 0°C to generate the free carbene, which is trapped in situ with a suitable metal precursor—typically [Rh(COD)Cl]₂, [Ir(COD)Cl]₂, or PdCl₂(PhCN)₂—to form the corresponding N,S-heterocyclic carbene metal complex. The 5-methyl substituent provides sufficient steric differentiation from the ring nitrogen to orient the carbene's lone pair for optimal metal coordination, while the sulfur atom's electron donation into the carbene center moderates the σ-donating strength relative to imidazol-2-ylidenes. Infrared spectroscopy of the resulting metal carbonyl complexes (obtained by CO displacement of COD) records ν(CO) stretching frequencies that are 5–15 cm⁻¹ lower than those of the analogous imidazole-derived NHC complexes, confirming enhanced π-backdonation from the metal into the CO ligand—a consequence of the lower net donor strength of the thiazole-derived carbene ligand.Publication data for thiazole-derived carbene ligands is concentrated in academic organometallic chemistry, and the translation of these ligand systems to industrial-scale homogeneous catalysis has been limited. The primary barrier is the multi-step sequence required to convert 2-bromo-5-methylthiazole into the active ligand precursor, coupled with the sensitivity of the free carbene to air and moisture. In research laboratories operating Schlenk-line or glovebox techniques, the free carbene is generated and used in situ without isolation, and reported catalyst turnover numbers for model Suzuki and hydroformylation reactions are modest (TON 500–2,000) compared to established NHC and phosphine systems. The thiazole-derived carbene ligand class occupies a specialized niche where the unique electronic tuning provided by the ring sulfur is required—specifically in transformations where excessively strong σ-donation from conventional NHCs leads to catalyst deactivation via over-stabilization of the resting state.The total synthesis of thiazole-containing macrocyclic natural products—epothilones, cystothiazoles, myxothiazoles, and the thiopeptide antibiotic class—relies on the convergent assembly of the thiazole heterocycle from pre-functionalized fragments or the late-stage functionalization of a pre-formed thiazole core. 2-Bromo-5-methylthiazole supplies a thiazole building block with the methyl substituent pre-installed at C5 and a reactive bromine at C2, enabling fragment coupling without the need for protecting group manipulation at the methyl-bearing carbon. In the epothilone class, the thiazole ring is incorporated as a side-chain heterocycle attached via a vinyl linkage; the 2-bromo substituent of 2-bromo-5-methylthiazole undergoes Stille or Suzuki coupling with a vinylstannane or vinylboronate representing the macrolactone fragment, installing the thiazole directly at the C2 position. The coupling is executed at 80–100°C in DMF or NMP with Pd(PPh₃)₄ (5–10 mol%) and copper(I) iodide (10–20 mol%) as a co-catalyst for Stille conditions, or with PdCl₂(dppf) and aqueous base for Suzuki conditions. Yields for this fragment coupling step, as reported across multiple epothilone synthetic campaigns, cluster in the 55–75% range and are limited by competitive homocoupling of the vinyl organometallic reagent under the elevated temperatures required for oxidative addition into the 2-bromothiazole. Copper(I) thiophene-2-carboxylate (CuTC) as a stoichiometric additive at 1.5–2.0 equivalents improves Stille coupling rates through transmetalation acceleration, lifting isolated yields to 70–82% in the synthesis of epothilone B analogues. The 5-methyl substituent of the 2-bromo-5-methylthiazole starting material corresponds to the methyl group present in the natural epothilone A, B, and D structures; thus the building block avoids a C5 alkylation step that would otherwise require lithiation chemistry and introduce regioselectivity complications.Thiopeptide antibiotics—including nosiheptide, thiostrepton, and GE2270 A—incorporate multiple thiazole and thiazoline rings within their macrocyclic peptide scaffolds, and 2-bromo-5-methylthiazole can function as a late-stage precursor for the introduction of specific thiazole residues during total synthesis. The bromine at C2 is displaced by a thioamide or by a cysteine-derived unit that, upon cyclodehydration, forms the fused thiazole ring system. This chemistry has been demonstrated at research scale in the synthesis of truncated thiopeptide fragments, though the full-scale total synthesis of nosiheptide incorporating 2-bromo-5-methylthiazole-derived intermediates has not been reported in a single convergent sequence. The compound's utility in natural product synthesis is therefore most established in the epothilone and cystothiazole families, where multiple published routes explicitly identify 2-bromo-5-methylthiazole or its boronic ester derivative as the thiazole source in key fragment coupling steps.

Process-Scale Handling and Quality Specifications for Multi-Kilogram Pharmaceutical Intermediate Supply

When 2-bromo-5-methylthiazole is procured as a regulated pharmaceutical intermediate under Good Manufacturing Practice conditions, the material must conform to a predefined specification encompassing identity, assay, impurity profile, residual solvents, and elemental impurities. The standard release assay by GC (flame ionization detection, DB-5 or equivalent capillary column, 30 m × 0.32 mm × 0.25 μm film thickness) requires a purity of not less than 98.0 area%, with the principal impurity—typically the debrominated analogue 5-methylthiazole—controlled at ≤1.0 area%. The dibrominated impurity 2,4-dibromo-5-methylthiazole, arising from over-bromination during manufacture of the starting material, is limited to ≤0.5 area% due to its potential to generate bis-arylated impurities in downstream Suzuki couplings. Water content by Karl Fischer titration (coulometric or volumetric per USP 〈921〉) must not exceed 0.5 wt% to avoid hydrolysis of the C2 bromine during prolonged storage; material stored under nitrogen at 2–8°C in amber glass or HDPE containers retains specification purity for 24–36 months. The compound exhibits a density of approximately 1.55–1.65 g/mL at 20°C and is a pale yellow to light amber liquid with a boiling point of 85–90°C at 15 mmHg. It is classified as a combustible liquid with a flash point of 88–95°C (closed cup, ASTM D93) and must be stored away from strong oxidizing agents and strong bases. Shipment of multi-kilogram quantities in 200 L HDPE drums or 1,000 L IBC totes is conducted under nitrogen blanket, and receiving facilities must be equipped to transfer the material into temperature-controlled storage within 8 hours of container opening to prevent moisture ingress. For facilities performing the Suzuki coupling at scale, the material is charged to the reactor via a nitrogen-purged addition funnel or diaphragm pump with PTFE wetted components; extended contact with carbon steel or copper alloys must be avoided, as trace metal leaching from equipment surfaces can seed premature catalyst decomposition or promote non-productive coupling pathways that consume the palladium catalyst.

Parameter	Method	Acceptance Criterion	Rationale
Assay (purity)	GC-FID / HPLC-UV	≥98.0%	Pharmaceutical intermediate minimum purity per ICH Q7 Section 11
5-Methylthiazole (debrominated impurity)	GC-FID	≤1.0%	Acts as chain terminator in polymerization; inert diluent in cross-coupling
2,4-Dibromo-5-methylthiazole	GC-FID / LC-MS	≤0.5%	Generates bis-arylated impurities in Suzuki; purging difficult at penultimate stage
Water (KF)	USP 〈921〉 Method Ia	≤0.5 wt%	Hydrolytic debromination accelerates above 0.5% H₂O; exotherm risk in lithiation
Residual palladium	ICP-MS (USP 〈232〉)	≤2 ppm	Carryover from supplier synthesis; oral PDE 100 μg/day
Residual solvents	GC-HS (USP 〈467〉)	ICH Q3C Class 2/3 limits	Typical residual: dichloromethane ≤600 ppm, THF ≤720 ppm
Appearance	Visual (against white/black background)	Pale yellow to light amber, clear liquid	Darkening indicates thermal or photolytic decomposition; turbidity signals moisture ingress